Management of acne vulgaris: what does NICE recommend?
Rebecca Penzer-Hick outlines the recommendations from NICE Guideline 198 on acne vulgaris, and explains how treatment differs according to severity of disease
Adopt a stepped approach to atopic eczema management
Dr Caroline Ward discusses NICE recommendations on the treatment of atopic eczema, focusing on eczema complicated by bacterial or viral infection
Acne vulgaris: manage patient expectations and optimise treatment
Dr Kash Bhatti and Dr Bruce Pollock summarise the recently updated PCDS pathway on acne vulgaris and outline what to consider when managing the condition
Infective skin conditions: when is it appropriate to prescribe an antibiotic?
Dr Caroline Ward summarises updated NICE guidance on assessing and prescribing for impetigo, cellulitis and erysipelas, leg ulcer infection, and diabetic foot infections in primary care
Actinic keratosis: PCDS updates guidance on primary care management
Dr Kash Bhatti highlights recent updates to the PCDS pathway on actinic keratosis and considerations when assessing and managing this common condition
Educational resources
Klisyri▼ (tirbanibulin) 10 mg/g ointment
This formulary decision guide was developed from content provided by Almirall Ltd in a format developed by Guidelines in Practice. It was commissioned by Almirall Ltd, who carried out full medical approval to ensure compliance with regulations.
View prescribing and adverse event reporting information
UK-KLI-2100017 | Date of preparation: October 2021
Disease-modifying anti-rheumatic drugs (DMARDS) guidelines: a focus on methotrexate guidance in clinical practice
Information intended for UK healthcare professionals only. This webinar was initiated and commissioned by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
View Methofill® (methotrexate) pre-filled injector and pre-filled syringe prescribing information and adverse event reporting information here
View the Summary of Product Characteristics for Folic Acid 5mg Tablets; Legal Cat POM; NHS List price 90p
UK-02645
Date of preparation: September 2021
Implementing the NICE guideline on the management of acne vulgaris
Information intended for UK healthcare professionals only.
Methofill® (methotrexate) SelfDose for the treatment of adult patients with rheumatoid arthritis, Crohn’s disease, and psoriasis*
Intended for UK Healthcare professionals only.
This promotional supplement has been commissioned and funded by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
Click here for Methofill® (methotrexate) prescribing information and adverse event reporting
For full indications, please consult the summary of product characteristics.
UK-03037 | Date of preparation: May 2021
Recommending emollients for patients with atopic dermatitis or dry skin conditions
This supplement has been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines.
Date of preparation: January 2021